CoreWeave's stock closed down 16.31% after CEO Mike Intrator noted delays at a data center provider that Jim Cramer implied is Core Scientific; CORZ fell 10%+
Welcome to Runtime! Today: An update on our independent journalism mission … Bluesky: Tero Kuittinen / @teroterotero : You must invest in Nvidia because AI chips need to be replaced every 2 years. And also invest in Coreweave, because AI chips last for 10 years. Schrödinger's Chip depreciates fully in 3 years, or 6, or 10. Maybe 5 or 8. It's just a detail, or a quibble. Ed Zitron / @edzitron.com : CoreWeave has basically five customers: OpenAI, Microsoft (mostly OpenAI), Google (renting capacity to rent to OpenAI), Meta, and of course NVIDIA. This has been a huge, obvious problem for a long time and because the markets are stupid it's only just becoming one for traders Gary Marcus / @garymarcus : 👉Softbank sells entire Nvidia position. — 👉Oracle debt downgraded. — 👉Meta financing games revealed. — 👉OpenAI CEO @sama couldn't explain how company would meet its $1.4 T obligations. — 👉Coreweave drops 20% in a week. — You do the math. … Mastodon: Dare Obasanjo / @carnage4life@mas.to : CoreWeave cut its revenue forecast from $5.15B - $5.35B to $5.05B - $5.15B due to delays in getting data center capacity from a vendor. The stock is down -16%. — This highlights both the trend of outsized punishment from investors over relatively small misses and how power & datacenters not chips are now the limiting factor for AI service provider growth. … Forums: r/wallstreetbets : CoreWeave CEO responds to data center delays as stock plunges. Core Scientific shares fall
Context & Ripple Effects
CoreWeave entered the public market after a reduced IPO, while pre-IPO reporting had already tied a major customer relationship to delivery issues and missed deadlines. The latest guidance cut puts data-center execution, rather than AI-compute demand alone, at the center of investor scrutiny.
The company had also agreed to acquire Core Scientific to expand AI data-center capacity, making the market’s focus on a potentially affected provider especially consequential—even though the provider was not formally identified in the reported guidance update.
First-order effects
- CoreWeave lowered its revenue forecast to $5.05B–$5.15B from $5.15B–$5.35B because capacity from a vendor was delayed; its shares closed down 16.31%.
- Core Scientific shares fell more than 10% after Jim Cramer implied it was the delayed provider, an attribution not confirmed by CoreWeave in the supplied reporting.
Second-order effects
- The selloff raises the cost of execution uncertainty for CoreWeave as it builds capacity for a concentrated group of major AI customers; investors will likely distinguish contracted demand from data-center delivery capability.
- The episode puts additional emphasis on the rationale and integration stakes of CoreWeave's proposed Core Scientific acquisition, which was intended to add AI data-center capacity.
Third-order effects
- If capacity schedules repeatedly constrain revenue recognition, AI-compute providers may be valued less as pure demand beneficiaries and more on construction, power, and vendor-delivery discipline.
- The pattern would reinforce a shift in AI infrastructure finance toward tighter scrutiny of whether funded capacity can be brought online reliably, rather than of backlog alone.
The trend: AI infrastructure is becoming a delivery-and-financing execution story as much as a race to secure demand and chips.